Trump's Pharma Tariff: A Win for Big Pharma?
Update: 2025-09-26
Description
Trump Doubles Down: Pharma Faces 100% Import Tariff if They Don't Build in the US! Find out which drug giants like Novo Nordisk and Merck are already building stateside to dodge the hit, and why investors aren't panicking. Is this a game-changer or just a headline? We break down the potential impact, trade deal loopholes, and why it might actually be a win for Big Pharma.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
